Under the current centralized system, drug development happens in silos. 

Pharmaceutical companies don’t share information. Scientists run the same failed experiments over and over again. And the process of bringing a drug to market typically takes ten-plus years. 

But Paul Kohlhaas and Tyler Golato are building a new way to do drug development. A system that allows for collaboration and dramatically increases the speed of breakthroughs in healthcare. 

CEO Paul and CSO Tyler are the Cofounders of Molecule, a decentralized biotech protocol that establishes a Web3 marketplace for research-related intellectual property. 

On this episode of Boost VC, Paul and Tyler join us to explain how their personal experiences with the failures of healthcare inspired their interest in changing the system. 

They discuss Molecule's end-to-end ecosystem for bringing drugs to market, describing how their IP-NFT both protects innovation and makes it more open, sharable and collaborative. 

Listen in for insight on Eroom's Law and learn how open science leads to enormous efficiency gains in the drug development process.

Topics Covered

How Paul & Tyler define science

• Empirical discovery of knowledge
• Progressive search for truth

What inspired Paul & Tyler’s interest in science

• Personal experience with failures of healthcare
• Potential for DeSci to foster new behaviors

Paul & Tyler’s failed experiment with crowdfunding

• Tried to raise money for microdosing study
• Partnership with University of Toronto

How Molecule has evolved since 2019

• Ecosystem for bringing drugs to market
• IP-NFT framework for collaboration

How to make scientists more open to sharing

• Improve user experience
• Streamline funding process

The power of Molecule’s IP-NFT framework

• Intellectual property rights held on chain
• Collectively owned by patients

The value prop for open science

• Creates enormous efficiency gains
• Makes drug development much cheaper

Jack Scannel’s naming of Eroom’s Law

• Technology to discover drugs improving
• Yet drug discovery output in decline

The goals for DeSci over the next decade

• Extend quality of human health span
• Make science self-sovereign, self-aware

How Paul & Tyler define success

• Remain true to values and vision for life
• Net positive impact on every person

Connect with Paul Kohlhaas & Tyler Golato

Molecule https://www.molecule.to/

Molecule on GitHub https://github.com/moleculeprotocol

Molecule on Discord https://discord.com/invite/uAGW7K4hQU

Molecule on YouTube https://www.youtube.com/channel/UCWYW5ho3L_d0EO_a619E7RQ

Molecule on LinkedIn https://www.linkedin.com/company/molecule-protocol  

Molecule on Twitter https://twitter.com/molecule_dao

Paul on Twitter https://twitter.com/paulkhls

Tyler on Twitter https://twitter.com/GolatoTyler

Resources

Linum Labs https://www.linumlabs.com/

Molecule’s Crowdfunding Experiment with the University of Toronto https://www.molecule.to/blog/psychedelics-on-the-blockchain

NIH Grants and Funding https://www.nih.gov/grants-funding

Simon de la Rouviere on Bonding Curves https://www.youtube.com/watch?v=-k4M6QAW2pM

Jack Scannell on Eroom’s Law https://refoundable.com/research/life-after-erooms-law-interview-with-jack-scannell.html

Meme Lordz https://memelordz.io/

North American Association of Technology Transfer http://aim.autm.net/

Ray Kurzweil https://www.kurzweilai.net/

Peter Diamandis https://www.diamandis.com/

Abundance 360 https://www.abundance360.com/summit

Connect with Boost VC

Boost VC Website https://www.boost.vc/

Boost VC on Facebook https://www.facebook.com/boostvc/

Boost VC on Twitter https://twitter.com/BoostVC

Boost VC on Instagram https://www.instagram.com/boost_vc/